0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The relationship between homocysteine and cardiopulmonary exercise testing in patients with acute coronary syndrome after percutaneous coronary intervention

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objective

          The purpose of this study was to investigate the relationship between homocysteine (Hcy) levels and cardiopulmonary exercise testing (CPET) in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). We also explored the relationship between Hcy levels and cardiac ultrasonography.

          Methods

          This study comprised 261 patients with ACS who underwent coronary angiography and PCI at Yulin First Hospital from January 2020 to June 2021. All subjects completed basic data collection, laboratory examination, CPET and cardiac ultrasonography. The CPET includes the peak oxygen uptake (peak VO 2), anaerobic threshold (AT), metabolic equivalents (METs), exercise load (load), oxygen pulse (O 2 pulse), end-tidal CO 2 partial pressure (PETCO 2), ventilatory equivalents for carbon dioxide (VE/VCO 2) and Oxygen uptake efficiency (OUES). Cardiac ultrasonography was used to evaluate the left ventricular end diastolic diameter (LVEDD), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT) and left ventricular ejection fraction (LVEF). A serum Hcy level ≥ 15 µmol/L was defined as hyperhomocysteinemia (HHcy). The patients were divided into the Hcy < 15 µmol/L group (n = 189) and the Hcy ≥ 15 µmol/L group (n = 72).

          Results

          The average age of the participating patients was 58.9 ± 10.1 years. The majority of participants were male (86.6%). The CPET indices of METs, load, VO 2/kg, and PETCO 2 were significantly decreased in the Hcy ≥ 15 µmol/L group compared with the Hcy < 15 µmol/L group. Additionally, the CPET index of the VE/VCO 2 slope and the cardiac ultrasonography indices of IVST and LVPWT were significantly increased in the Hcy ≥ 15 µmol/L group compared with the Hcy < 15 µmol/L group. These differences were statistically significant ( P < 0.05). Correlation analysis showed that Hcy levels were negatively correlated with METs, VO 2/kg and PETCO 2 and positively correlated with the VE/VCO 2 slope ( P < 0.05). Partial correlation analysis showed that Hcy levels were negatively correlated with METs and VO 2/kg in the AT state. The correlation coefficients were − 0.172 and − 0.172, respectively ( P < 0.05). Hcy levels were negatively correlated with METs, VO 2/kg and PETCO 2 in the peak state. The correlation coefficients were − 0.177, -0.153 and − 0.129, respectively ( P < 0.05). After further adjustment for confounders, multiple linear regression analysis showed that Hcy levels were negatively correlated with METs and VO 2/kg in the AT state and peak state. The standardized regression coefficients were − 0.035, -0.122, -0.048 and − 0.128, respectively ( P < 0.05). Correlation analysis showed that Hcy levels were positively correlated with the IVST and LVPWT ( P < 0.05), but after adjusting for confounding factors, partial correlation analysis showed that there was no correlation between them.

          Conclusion

          A high Hcy level is associated with lower METs and VO 2/kg and worse cardiopulmonary function in patients with ACS after PCI.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: not found
          • Article: not found

          Exercise standards for testing and training: a scientific statement from the American Heart Association.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hypertrophy of the heart: a new therapeutic target?

              Recent studies call into question the necessity of hypertrophic growth of the heart as a "compensatory" response to hemodynamic stress. These findings, coupled with recent progress in dissecting the molecular bases of hypertrophy, raise the prospect of suppressing hypertrophy without provoking circulatory insufficiency. In this article, we focus on signaling pathways that hold promise as potential targets for therapeutic intervention. We also summarize observations from animal models and clinical trials that suggest benefit from an antihypertrophic strategy.
                Bookmark

                Author and article information

                Contributors
                zhiyuzeng@163.com
                Journal
                BMC Cardiovasc Disord
                BMC Cardiovasc Disord
                BMC Cardiovascular Disorders
                BioMed Central (London )
                1471-2261
                6 January 2023
                6 January 2023
                2023
                : 23
                : 3
                Affiliations
                [1 ]GRID grid.412594.f, ISNI 0000 0004 1757 2961, Department of Cardiology, , The First Affiliated Hospital of Guangxi Medical University, ; Nanning, Guangxi China
                [2 ]Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention and Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases, Nanning, Guangxi China
                [3 ]GRID grid.256607.0, ISNI 0000 0004 1798 2653, Department of Cardiology, The Sixth Affiliated Hospital, , Guangxi Medical University, ; Yulin, Guangxi China
                Article
                2976
                10.1186/s12872-022-02976-0
                9817365
                36609219
                de66da83-e07f-430f-8426-f091151cdbc5
                © The Author(s) 2023

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 1 March 2022
                : 24 November 2022
                Funding
                Funded by: Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention
                Award ID: No. 20-065-73
                Award Recipient :
                Funded by: Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases
                Award ID: No.AD17129014
                Award Recipient :
                Funded by: Guangxi Medical High-level Backbone Talents "139" Program
                Award ID: No.G201901006
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2023

                Cardiovascular Medicine
                homocysteine,acute coronary syndrome,cardiopulmonary exercise testing

                Comments

                Comment on this article